XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
RSUs
Common Stock
Common Stock
RSUs
Additional Paid-In Capital
Additional Paid-In Capital
RSUs
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance, shares (in shares) at Apr. 30, 2022     106,225          
Beginning Balance, Amount at Apr. 30, 2022 $ 989,477   $ 106   $ 1,532,917   $ (2,148) $ (541,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)     278          
Issuance of Class A common stock upon exercise of stock options, net of repurchases 1,101       1,101      
Vesting of early exercised Class A common stock options 333       333      
Vesting of restricted stock units (in shares)       1,841        
Vesting of restricted stock units   $ 13,671   $ 2   $ 13,669    
Stock-based compensation expense 46,467       46,467      
Other comprehensive loss (200)           (200)  
Net loss (71,871)             (71,871)
Ending Balance, shares (in shares) at Jul. 31, 2022     108,344          
Ending Balance, Amount at Jul. 31, 2022 978,978   $ 108   1,594,487   (2,348) (613,269)
Beginning Balance, shares (in shares) at Apr. 30, 2023     113,943          
Beginning Balance, Amount at Apr. 30, 2023 $ 929,665   $ 113   1,740,174   (385) (810,237)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares) 2,086   2,084          
Issuance of Class A common stock upon exercise of stock options, net of repurchases $ 9,571   $ 2   9,569      
Vesting of early exercised Class A common stock options 151       151      
Shares withheld related to net share settlement of equity awards (in shares)     (172)          
Shares withheld related to net share settlement of equity awards (7,118)       (7,118)      
Vesting of restricted stock units (in shares)       2,070        
Vesting of restricted stock units   $ 21,468   $ 2   $ 21,466    
Stock-based compensation expense 43,436       43,436      
Other comprehensive loss (373)           (373)  
Net loss (64,358)             (64,358)
Ending Balance, shares (in shares) at Jul. 31, 2023     117,925          
Ending Balance, Amount at Jul. 31, 2023 $ 932,442   $ 117   $ 1,807,678   $ (758) $ (874,595)